Data are presented of 368/503 post-COVID-19 outpatients followed within the AntiCROWN Cohort who have a one-year control and a baseline assessment of anti-S1/S2 antibodies, detected with the The LIAISON® SARS-CoV-2 S1/S2 IgG solution by DiaSorin. Loss of response occurred in 4 subjects having a baseline level below 50 AU/mL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158344 | PMC |
| http://dx.doi.org/10.1016/j.jinf.2021.05.023 | DOI Listing |
Publication Analysis
Top Keywords
anti-spike igg
8
one-year durability
4
durability anti-spike
4
igg sars-cov-2
4
sars-cov-2 preliminary
4
preliminary data
4
data anticrown
4
anticrown prospective
4
prospective observational
4
observational study
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!